JD

Jerel Davis

Managing Director at Versant Ventures

Greater Vancouver Metropolitan Area

Overview 

Jerel Davis is the Managing Director at Versant Ventures, overseeing investments in various biotechnology and pharmaceutical companies. With a PhD from Stanford University and a background in leading successful Series A to Series D investments in companies like Firefly Bio and Turnstone Biologics, he has demonstrated expertise in corporate development, venture capital, and strategic planning within the life sciences industry. Davis also serves as the Lead Board Director at Chinook Therapeutics, showcasing his leadership and strategic acumen in guiding companies towards successful growth and commercialization.

Work Experience 

BB

Borealis Biosciences, Inc.

  • Board Chair

    2024 - Current

VV

Versant Ventures

  • Managing Director

    2011

    Current companies: Ventus Tx, Kolm Tx, Borealis Bio, Tentarix Bio, Santa Ana Bio, FireFly Tx, Fable Tx, Turnstone Bio Example previous companies: Chinook Tx (KDNY), RayzeBio, (RYZB), BlueRock (Acq. Bayer), Crispr Tx (CRSP), Repare Tx (RPTX), Quanticel Pharmaceuticals (Acq. Celgene), Akero Therapeutics (AKRO), Inception 4 (Acq. Iveric), Inception 5 (Acq. Roche), Northern Biologics (Acq. AZ and BI), Graphite Bio (now LENZ), Nested Tx,

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

versantventures.com
VT

Ventus Therapeutics

  • Board Chair

    2020

Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.

Raised $370,150,000.00 from Michael J. Fox Foundation.

ventustx.com
FB

Firefly Biologics

  • Board Member

    2022

SA

Santa Ana Bio

  • Board Chair

    2022

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Raised $176,024,658.00 from Andreessen Horowitz, RTW Investments, Access Biotechnology and Google Ventures.

santaanabio.com
KT

Kolm Therapeutics

  • Board Member

    2022

TB

Tentarix Biotherapeutics, Inc.

  • Board Member

    2020

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

Raised $93,000,000.00 from Gilead Sciences, Amplitude Venture Capital, Versant Ventures and Samsara BioCapital.

tentarix.com
TB

Turnstone Biologics

  • Board Member

    2015

Turnstone Biologics is a privately-held clinical stage biotech company.

Raised $132,699,979.00 from Brace Pharma, Ridgeback Capital, PFM Health Sciences, Point72, Northleaf Capital Partners, Surveyor Capital, Sixty Degree Capital, Teralys Capital, JM Family Enterprises and Versant Ventures.

turnstonebio.com
NT

Nested Therapeutics

  • Board Member

    2022 - 2023

Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.

Raised $125,000,000.00 from Avidity Partners, Foresite Capital, Goldman Sachs Asset Management, Section 32 and Cowen Healthcare Investments.

nestedtx.com
CT

Chinook Therapeutics, Inc.

  • Lead Board Director

    2019 - 2023

Education 

Investments 

Firefly Bio

Series A

Total funding: $94M

Tentarix Biotherapeutics

Series A

Total funding: $85M

Santa Ana Bio

Series A

Total funding: $170M

Ventus Therapeutics

Series A

Total funding: $300M

Articles About Jerel

Relevant Websites